ImmunityBio (IBRX) Meeting With Turkish President Fuels Expansion Hopes, Shares Climb 10%

September 23, 2026 - 10:04

ImmunityBio Inc. shares climbed nearly 10 percent on Tuesday, closing at $9.29 each, after a meeting between the company's founder, Dr. Patrick Soon-Shiong, and Turkish President Recep Tayyip Erdogan raised expectations about a possible expansion into Turkey.

The Turkish government shared an image of the two men on social media, which quickly drew attention from investors and analysts tracking the biotech firm. The company, which trades on the NASDAQ under the ticker IBRX, has been working to broaden the reach of its immunotherapy treatments, and Turkey represents a potentially significant market given its large population and growing healthcare sector.

The meeting comes at a time when ImmunityBio is seeking to strengthen its international footprint and build partnerships that could speed up the adoption of its cancer therapies. While no formal agreement has been announced, the encounter was enough to push the stock higher as traders bet on new opportunities in the region.

Investors have been watching the company closely in recent months, with its share price showing sensitivity to news about clinical progress and business deals. Tuesday's gain reflects how much weight the market places on strategic moves that could open new revenue streams.

It remains unclear what specific topics were discussed during the meeting or whether any concrete plans will follow. For now, the market has responded with clear enthusiasm, and further updates from the company or Turkish officials could shape how the stock performs in the days ahead.